Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
32.52
-1.68 (-4.91%)
At close: Nov 6, 2026, 4:00 PM EST
32.68
+0.16 (0.48%)
After-hours: Nov 6, 2026, 7:59 PM EST
Castle Biosciences Employees
Castle Biosciences had 1,048 employees as of September 30, 2026. The number of employees increased by 225 or 27.34% compared to the same quarter last year. That makes Castle Biosciences the 14,511th largest employer in the world and 2,145th in the United States.
Employees
1,048
Change (1Y)
225
Growth (1Y)
27.34%
Revenue / Employee
$359,853
Profits / Employee
-$21,960
Market Cap
1.00B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2026 | 1,048 | 225 | 27.34% | 1,048 | 0 |
| Jun 30, 2026 | 1,002 | 204 | 25.56% | 1,002 | 0 |
| Mar 31, 2026 | 942 | 158 | 20.15% | 942 | 0 |
| Dec 31, 2025 | 883 | 122 | 16.03% | 883 | 0 |
| Sep 30, 2025 | 823 | 113 | 15.92% | 823 | 0 |
| Jun 30, 2025 | 798 | 95 | 13.51% | 798 | 0 |
| Mar 31, 2025 | 784 | 146 | 22.88% | 784 | 0 |
| Dec 31, 2024 | 761 | 151 | 24.75% | 761 | 0 |
| Sep 30, 2024 | 710 | 123 | 20.95% | 710 | 0 |
| Jun 30, 2024 | 703 | 121 | 20.79% | 703 | 0 |
| Mar 31, 2024 | 638 | 95 | 17.50% | 638 | 0 |
| Dec 31, 2023 | 610 | 67 | 12.34% | 610 | 0 |
| Sep 30, 2023 | 587 | 70 | 13.54% | 587 | 0 |
| Jun 30, 2023 | 582 | 100 | 20.75% | 582 | 0 |
| Dec 31, 2022 | 543 | 198 | 57.39% | 542 | 1 |
| Sep 30, 2022 | 517 | 206 | 66.24% | 517 | 0 |
| Jun 30, 2022 | 482 | 190 | 65.07% | 482 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sotera Health Company | 3,000 |
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| CareDx | 765 |
| Veracyte | 755 |
CSTL News
- 2 days ago - Castle Biosciences price target raised to $40 from $35 at KeyBanc - TheFly
- 2 days ago - Castle Biosciences price target raised to $39 from $38 at Baird - TheFly
- 2 days ago - Castle Biosciences reports Q3 adjusted EPS (13c), consensus (35c) - TheFly
- 2 days ago - Castle Biosciences raises 2026 revenue view to $385M-$395M from $345M-$355M - TheFly
- 2 days ago - Castle Biosciences Earnings Call Transcript: Q3 2026 - Transcripts
- 2 days ago - Castle Biosciences Earnings release: Q3 2026 - Filings
- 2 days ago - Castle Biosciences Quarterly report: Q3 2026 - Filings
- 2 days ago - Castle Biosciences Slides: Q3 2026 - Filings